Cipher Pharmaceuticals stock forecast
Want to see TSE:CPH full AI Analyst Report?
Cipher Pharmaceuticals (CPH) Stock Forecast & Price Target
CPH Analyst Ratings
CPH Stock 12 Month Forecast
Average Price Target
C$20.00▲(49.25% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Justin Keywood | Stifel Nicolaus | C$20 | buy | 49.25%Upside | Reiterated | 11/16/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Justin KeywoodStifel Nicolaus | BuyReiteratedC$20 | 11/16/26 | 49.25%Upside |
Best Analysts Covering Cipher Pharmaceuticals
Copying Justin Keywood's trades and holding each position for 3 Months would result in 38.10% of your transactions generating a profit, with an average return of -1.17% per trade.
Copying Justin Keywood's trades and holding each position for 1 Year would result in 47.62% of your transactions generating a profit, with an average return of +11.85% per trade.
Copying Justin Keywood's trades and holding each position for 2 Years would result in 38.10% of your transactions generating a profit, with an average return of +6.25% per trade.
CPH Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 3 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 2 | 3 | 2 | 2 |
In the current month, CPH has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CPH average Analyst price target in the past 3 months is 20.00.
CPH Financial Forecast
CPH Earnings Forecast
Next quarter’s earnings estimate for CPH is CAD 0.29 with a range of CAD 0.23 to CAD 0.40. The previous quarter’s EPS was CAD 0.60. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
CPH Sales Forecast
Next quarter’s sales forecast for CPH is CAD 18.18M with a range of CAD 16.79M to CAD 19.70M. The previous quarter’s sales results were CAD 17.78M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

